News Center
The Deputy Director of the National Development and Reform Commission visited Lizhu for research.
Release time:
2017-07-06
To promote the accelerated development of the biopharmaceutical industry and support strong pharmaceutical companies to grow larger and stronger, this morning, Shen Zhulin, Deputy Director of the High-Tech Industry Department of the National Development and Reform Commission, visited the Lizhu Industrial Park for an on-site investigation to understand the development situation of the enterprise. Tao Desheng, President of Lizhu Group, and Zhou Peng, Vice President, accompanied Deputy Director Shen to visit the intelligent logistics system of Lizhu Industrial Park and introduced the development overview of Lizhu in the exhibition hall. In the intelligent elevated warehouse of Lizhu Industrial Park, unmanned AGV carts shuttle back and forth, accurately storing finished products in an orderly manner. President Tao introduced this intelligent logistics system to Deputy Director Shen while touring, which uses all imported equipment and has achieved unmanned operation.
To promote the accelerated development of the biopharmaceutical industry and support capable pharmaceutical companies to grow stronger, this morning, Shen Zhulin, Deputy Director of the High-tech Industry Department of the National Development and Reform Commission, visited the Lizhu Industrial Park for an on-site investigation to understand the company's development situation. Lizhu Group President Tao Desheng and Vice President Zhou Peng accompanied Deputy Director Shen to visit the intelligent logistics system of the Lizhu Industrial Park and introduced the development overview of Lizhu in the exhibition hall.
In the intelligent elevated warehouse of the Lizhu Industrial Park, unmanned AGV carts shuttle back and forth, accurately storing finished products in an orderly manner. President Tao introduced this intelligent logistics system to Deputy Director Shen while touring, explaining that the system uses all imported equipment, achieving precise inbound and outbound of finished products in an unmanned operating environment, minimizing the uncertainty and safety risks during the transfer of finished products, while also greatly reducing costs and improving efficiency. Deputy Director Shen stated that Lizhu has a high degree of production intelligence, and its pharmaceutical technology is at the leading level in the industry.
Lizhu started with gastrointestinal drugs, particularly Lizhu Dele, and after more than 30 years of steady development, it has formed three main businesses: formulations, active pharmaceutical ingredients, and in vitro diagnostics, while laying out the development pattern of the precision medical industry chain. President Tao introduced to Deputy Director Shen in the exhibition hall of the Lizhu Industrial Park that precision medicine is the strategic direction for Lizhu's future development, and a preliminary industrial chain has been established with Lizhu Monoclonal Antibody, Lizhu Shengmei, and Lizhu Gene as the main entities, forming a closed loop from disease diagnosis to treatment. This is a step for Lizhu towards becoming a hundred billion-level enterprise.
The nearly 2-meter-long astragalus and the about 1-meter-high agarwood specimens amazed Deputy Director Shen. The Lizhu Traditional Chinese Medicine exhibition hall displays nearly a hundred types of traditional Chinese medicine specimens, which Deputy Director Shen examined closely. Lizhu was the first in the country to propose the theory of digital traditional Chinese medicine and apply it to research and production. The first clear traditional Chinese medicine large-volume injection, Astragalus Injection, was born at Lizhu, and its efficacy has been widely recognized by doctors and patients.
Subsequently, Deputy Director Shen organized a symposium at the Lizhu Industrial Park with the development and reform bureaus of Shenzhen, Zhuhai, Dongguan, and Zhongshan to promote the accelerated development of the biopharmaceutical industry.Liu Zhi, General Manager of the Administrative Headquarters of Lizhu Group, Zhou Shufang, Deputy General Manager of the Administrative Headquarters, and Wu Quanhong, Deputy Director of Lizhu Pharmaceutical Factory, participated in the above activities.
Related Information